Clinical Trial Update: A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial assessing etanercept in children with Kawasaki disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Michael Portman | Conditions: Mucocutaneous Lymph Node Syndrome, Kawasaki Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06